RIGL - Rigel Pharmaceuticals
19.91
-0.520 -2.612%
Share volume: 146,445
Last Updated: 03-13-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.01%
PREVIOUS CLOSE
CHG
CHG%
$20.43
-0.52
-0.03%
Summary score
39%
Profitability
43%
Dept financing
25%
Liquidity
75%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-1.83%
Return on assets
-6.05%
Return on sales
-48%
Return on invested capital
40.52%
Total debt ratio
95.53%
Debt ratio change over timeo
-4.37%
Current Ratio
2.41%
Quick Ratio
2.29%
Cash Position Ratio
1.57%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
16.21%
Return on assets
-0.42%
Return on sales
-5.63%
Return on invested capital
15.75%
Total debt ratio
122.32%
Debt ratio change over timeo
-8.45%
Current Ratio
1.87%
Quick Ratio
1.74%
Cash Position Ratio
1.09%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
26.04%
Return on assets
-5.51%
Return on sales
-23.59%
Return on invested capital
21.06%
Total debt ratio
125.03%
Debt ratio change over time
-60.9%
Current Ratio
1.26%
Quick Ratio
1.17%
Cash Position Ratio
0.68%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-117.09%
Return on assets
-102.43%
Return on sales
-137.26%
Return on invested capital
-74.11%
Total debt ratio
-436.89%
Debt ratio change over time
-4.37%
Current Ratio
-3.1%
Quick Ratio
-2.86%
Cash Position Ratio
-1.17%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RIGL | LLY | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | -1.83% | 18.83% | 17.34% | 0% |
| Return on assets | -6.05% | 4.14% | 8.21% | 0% |
| Return on sales | -48% | 27.93% | 41.18% | 0% |
| Return on invested capital | 40.52% | 9.79% | -219.55% | 0% |
| Profitability | 25% | 61% | 73% | 0% |
| Total debt ratio | 95.53% | 82.52% | 55.88% | 0% |
| Debt ratio change over time | -4.37% | -13.08% | -0.73% | 0% |
| Dept financing | 25% | 22% | 15% | 25% |
| Current Ratio | 1.87% | 1.13% | 0% | 0% |
| Quick Ratio | 1.74% | 0.87% | 0% | 0% |
| Cash Position Ratio | 1.09% | 0.12% | 0% | 0% |
| Liquididy | 75% | 26% | 26% | 0% |
| Short-term ratios | RIGL | LLY | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | 16.21% | 13.31% | 0% | 0% |
| Return on assets | -0.42% | 4.46% | 0% | 0% |
| Return on sales | -5.63% | 29.96% | 0% | 0% |
| Return on invested capital | 15.75% | 10.68% | 0% | 0% |
| Profitability | 50% | 87% | 0% | 0% |
| Total debt ratio | 122.32% | 81.12% | 0% | 0% |
| Debt ratio change over time | -8.45% | -58.72% | 0% | 0% |
| Dept financing | 25% | 17% | 25% | 0% |
| Current Ratio | 1.87% | 1.13% | 0% | 0% |
| Quick Ratio | 1.74% | 0.87% | 0% | 0% |
| Cash Position Ratio | 1.09% | 0.12% | 0% | 0% |
| Liquididy | 75% | 30% | 0% | 0% |